Back

Mineralocorticoid receptor antagonists in heart failure with mildly reduced or preserved ejection fraction: a systematic review and meta-analysis of safety and clinical outcomes

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: From evidence to practice: optimising guideline-directed therapy and prevention Pharmacotherapy Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Rubiya Ali

Memorial Healthcare System, Pembroke Pines (United States of America)

6 More presentations in this session

Presentation thumbnail
Evaluating the impact of electronic alerts on guideline implementation of heart failure medical therapies in the Netherlands: the Dutch PROMPT-HF-study
Assistant Professor A. Uijl (Amsterdam, NL)
Abstract
Presentation thumbnail
Real-world implementation of guideline-directed medical therapy in heart failure across the ejection fraction spectrum: Insights from iCaReMe Global Registry
Doctor A. Hadaoui (Algiers, DZ)
Abstract
Presentation thumbnail
Nurse led titration of guideline-directed medical therapy for heart failure in Italy: an operative flow chart
Doctor M. Barisone (Rozzano, IT)
Abstract
Presentation thumbnail
The effect of influenza vaccination in patients with heart failure: a systematic review and meta-analysis
Mrs A. Freitas (Curitiba, BR)
Abstract
Presentation thumbnail
Revisiting Optimal Medical Therapy in HFrEF: Do Men and Women Need Different Doses? Evidence from KorAHF III registry
Doctor M. Kim (Seoul, KR)
Abstract

Access the full session

Session thumbnail
From evidence to practice: optimising guideline-directed therapy and prevention

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios
thumbnail
Congress Presentation
Audience Q&A
thumbnail
Congress Presentation
Did we forget ARNI in the era of SGLTi?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources